ListarArtículos (Medicina) por materia "Ulcerative colitis"
Mostrando ítems 1-7 de 7
-
Artículo
Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia
(Aran Ediciones S.A., 2022)Background: tofacitinib is a Janus kinase inhibitor approved for the treatment of moderate-severe ulcerative colitis ...
-
Artículo
Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?
(Aran Ediciones S.A., 2020)Introduction: endoscopy plays an essential role in the management of patients with ulcerative colitis (UC), as it allows ...
-
Artículo
Initial experience with golimumab in clinical practice for ulcerative colitis
(Aran Ediciones S.A., 2016)Background: Golimumab is a TNF-blocking agent indicated as a second-line therapy in ulcerative colitis. Purpose: To ...
-
Artículo
Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey
(Aran Ediciones S.A., 2017)colitis (UC) about their disease and access to a specialist are important to improve health outcomes. Our objective was ...
-
Artículo
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
(Original Research, 2019)Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated ...
-
Artículo
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
(Aran Ediciones S.A., 2018)Background and aims: infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of ...
-
Artículo
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
(Lippincott Williams & Wilkins, 2017)Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory ...